Uterine contractility and induction of abortion in early pregnancy by misoprostol and mifepristone
- 16 November 1991
- journal article
- clinical trial
- Published by Elsevier BV in The Lancet
- Vol. 338 (8777), 1233-1236
- https://doi.org/10.1016/0140-6736(91)92102-8
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Misoprostol and congenital malformationsThe Lancet, 1991
- Uterine activity and decidual prostaglandin production in women in early pregnancy in response to mifepristone with or without indomethacin in vivoHuman Reproduction, 1991
- A death associated with mifepristone/ sulprostoneThe Lancet, 1991
- Oral administration of RU 486 and 9-methylene PGE2 for termination of early pregnancyContraception, 1990
- CARDIAC STANDSTILL INDUCED BY PROSTAGLANDIN PESSARIESThe Lancet, 1989
- INDUCTION OF THERAPEUTIC ABORTION IN EARLY PREGNANCY WITH MIFEPRISTONE IN COMBINATION WITH PROSTAGLANDIN PESSARYThe Lancet, 1987
- Chemistry and synthetic development of misoprostolDigestive Diseases and Sciences, 1985
- Progesterone receptor blockageContraception, 1985
- Influence of the position of the side chain hydroxy group on the gastric antisecretory and antiulcer actions of E1 prostaglandin analogsProstaglandins, 1975
- EFFECTS OF ORAL ADMINISTRATION OF PROSTAGLANDINS E2 AND F2α ON THE HUMAN UTERUSBJOG: An International Journal of Obstetrics and Gynaecology, 1971